PancreasPlus app for monitoring recovery, symptoms, and education after pancreatic cancer treatment
Official title: A Prospective Study on the Use of an App (PancreasPlus) for Home Monitoring and Proactive Management of Patients With Pancreatic Cancer.
Run by Casa di Cura Dott. Pederzoli · NCT07532590 · Data updated 2026-11-12
This project will test whether the PancreasPlus app helps adults with pancreatic cancer and their caregivers monitor symptoms, get timely information, and communicate with their healthcare team.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 185 (estimated) |
| Sponsor | Casa di Cura Dott. Pederzoli Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Pavia, Pavia and 1 other locations) |
| Status | Recruiting |
| Started | February 26, 2026 |
| Main results expected | March 2027 |
| Study ends | April 2027 |
| Registry record updated | May 11, 2026 |
| Trial ID | NCT07532590 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with confirmed pancreatic cancer who have access to a smartphone or tablet, understand Italian, can give informed consent, and/or have a caregiver to help with the app are ideal candidates.
✕Probably not a fit
Patients with severe uncompensated cognitive impairment, no reliable smartphone/tablet access or data connection, or who cannot attend required follow-up are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Eligible adults with histologically or cytologically confirmed pancreatic cancer (and willing caregivers) will use the PancreasPlus smartphone or tablet app to complete periodic targeted questionnaires, access educational content, and communicate with their care team as part of routine follow-up. The intervention is delivered at participating centers in Pavia and Peschiera del Garda, Italy, and requires basic digital literacy or caregiver support plus Italian language comprehension. Study endpoints include feasibility, patient engagement, perceived quality of care, anxiety levels, and rates of unplanned hospital visits, with attention to any technological or privacy issues. Participation is excluded for those with severe uncompensated cognitive impairment or logistical barriers to follow-up.
Why it matters
Potential benefit: If successful, the app could improve patient engagement and self-management, lower anxiety, and reduce unplanned hospital visits after pancreatic cancer treatment.
How similar studies have gone: Some oncology programs using digital symptom monitoring and patient‑reported outcome tools have improved engagement and reduced unplanned visits, but dedicated app-based support for postoperative pancreatic cancer care is less well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18; diagnosis of pancreatic cancer (histological/cytological) * Access to a smartphone or tablet and a data connection; basic digital literacy or a caregiver available, * Ability to understand and provide informed consent; understanding of the Italian language. Exclusion Criteria: * Severe uncompensated cognitive impairment, * Social or logistical circumstances that prevent follow-up or access to/use of the app, * Refusal or withdrawal of consent.
Where it's running
-
Ospedale P. Pederzoli Casa di Cura Privata S.p.A.
Peschiera del Garda, Verona, Italy Recruiting -
U.O. Chirurgia Generale 1, IRCCS San Matteo, Università degli Studi di Pavia
Pavia, Pavia, Italy Active not recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
Dexmedetomidine as add-on for refractory cancer pain in palliative care
This study tests whether adding dexmedetomidine helps improve pain control for adults with cancer in palliative care whose pain remains high despite opioids.
-
Two Ways to Help Pain After Breast Surgery: Education-Based Analgesia vs Standard Care
This trial tests whether teaching patients about pain management and using a multimodal pain plan improves pain control and recovery after breast surgery compared with standard care.
-
Virtual Reality Therapy to Improve Arthroplasty Outcomes
This pilot test checks whether using virtual reality during the perioperative period helps knee or hip replacement patients feel better about their care and recover more easily.
-
Suzetrigine for pain relief after knee replacement
This trial tests whether suzetrigine can reduce opioid use after a total knee replacement compared with placebo.
-
Analgesic effects of adding BiFeS block to adductor canal block after ACL reconstruction
This study tests whether adding a BiFeS block to the standard adductor canal block provides better pain relief after ACL reconstruction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.